Amid panic buying of medicines in South Africa, Aspen is ramping up production

Different kinds of medicine
Different kinds of medicine

The pharmaceutical company Aspen is ramping up production of its over–the-counter pain, respiratory and colds and flu medicines after panic buying since the end of last week.

Orders for respiratory products, anti-inflammatory pain medications like Mybulen and Ibumol, as well as the cold and flu treatment Flusin have spiked. These medicines may be stockpiled to alleviated potential coronavirus symptoms, but other Aspen medicines like the antispasmodic treatment Hyospasmol have also been in massive demand.

Aspen will now redirect resources to increase production of some of these medicines – as a signal to the market to stop the panic buying.

Aspen Group CEO Stephen Saad told Fin24 that the orders for some medicines in a single day were the equivalent to 20% of a monthly order.

The panic buying was fuelled in part by a ban from India, the world’s biggest supplier of generic medicines, on exports of 26 pharmaceutical ingredients, including paracetamol.

“We want to tell people to remain calm. We have large factories, there will be enough supplies in South Africa. Our supply chain is robust, we have a lot of stock,” Saad said. 

Saad said that the panic buying could end up creating shortages for those who can’t afford to stock up, especially those who suffer from chronic conditions.

He said that Aspen has a commitment to the South African market, and will keep the local market fully supplied.

As the first human trial to test a vaccine against coronavirus began in the USv, Saad says that even if it was successful, the reality is that any vaccine will be available – at best – in only twelve months’ time.

ZAR/USD
17.48
(-0.28)
ZAR/GBP
22.89
(-0.51)
ZAR/EUR
20.70
(-0.54)
ZAR/AUD
12.53
(-0.23)
ZAR/JPY
0.16
(-0.28)
Gold
1934.31
(+0.65)
Silver
25.91
(+1.07)
Platinum
938.98
(+1.07)
Brent Crude
45.32
(+2.09)
Palladium
2141.00
(+0.83)
All Share
57333.27
(-0.15)
Top 40
53037.79
(-0.17)
Financial 15
10206.50
(+0.66)
Industrial 25
75869.19
(-0.45)
Resource 10
58907.63
(-0.14)
All JSE data delayed by at least 15 minutes morningstar logo
Company Snapshot
Voting Booth
Do you think it was a good idea for the government to approach the IMF for a $4.3 billion loan to fight Covid-19?
Please select an option Oops! Something went wrong, please try again later.
Results
Yes. We need the money.
11% - 981 votes
It depends on how the funds are used.
74% - 6511 votes
No. We should have gotten the loan elsewhere.
15% - 1348 votes
Vote